PARIS, March 19 — France’s health regulator recommended today that only people aged 55 and over be administered AstraZeneca’s Covid-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension. The regulator said the recommendation was...
A test tube labelled with the word Vaccine is seen in front of AstraZeneca logo in this illustration taken September 9, 2020. — Reuters picPARIS, March 19 — France’s health regulator recommended today that only people aged 55 and over be administered AstraZeneca’s Covid-19 vaccine due to reports of blood clots, while giving the green light to resume its use after a brief suspension.
Otherwise, use of the vaccine in France should be resumed “without delay” after its suspension earlier this week, it said. “I did not feel a thing even though I am a little squeamish,” the premier said at a hospital outside Paris. She said that while waiting for additional information, those under 55 should be vaccinated with the three other products approved in France: Pfizer/BioNTech, Moderna and Johnson & Johnson.